Skip to main content
SpringerLink
Log in

Does Eradication of Helicobacter pylori Infection Help Normalize Serum Lipid and CRP Levels?

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

It is still unclear whether Helicobacter pylori infection is associated with risk factors for coronary artery disease. The aim of this study was to determine whether eradication of H. pylori infection affects serum lipid levels and C-reactive protein (CRP) levels. Seventy-eight patients who had H. pylori antigen positivity in their stools were enrolled. Clarithromycin, 1 g/day, amoxicillin, 2 g/day, and omeprazole, 40 mg/day, were given for 14 days. Serum total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), and CRP were measured at baseline and 8 weeks after therapy. According to H. pylori stool antigen study after 8 weeks, individuals in whom H. pylori was eradicated were recruited as group A and those in whom H. pylori was not eradicated formed group B. Group A comprised 57 patients, and group B 21 patients. Patients in group A comprised 32 women and 25 men and their ages ranged from 35 to 59 years. Patients in group B included 13 women and 8 men, aged 32–61 years. No significant difference in LDL, TC, or TG serum levels were found between group A and group B. Although CRP and HDL serum levels were found to be the same before and after treatment in group B, CRP levels were found to decrease and HDL levels to increase significantly in group A (P < 0.05). We conclude that H. pylori infection may affect lipid metabolism in a way that could increase the risk of atherosclerosis. Thus H. pylori infection is an independent risk factor for coronary artery disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Roussos A, Philippou N, Gourgoulianis KI: Helicobacter pylori infection and respiratory diseases: a review. W J Gastroenterol 9(1):5–8, 2003

    Google Scholar 

  2. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P: Association of H. pylori infection with elevated serum lipids. Atherosclerosis 142:207–210, 1999

    Article  PubMed  Google Scholar 

  3. Kinjo K, Sato H, Sato H, et al.: Prevalence of H. pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circ J 66:805–810, 2002

    PubMed  Google Scholar 

  4. Niemela S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, Kesaniemi YA: Could H. pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 75:573–575, 1996

    PubMed  Google Scholar 

  5. Cammaroat G, Pasceri V, Gasbarrini A, Gabarrini G: Helicobacter pylori is an aetiologic factor for ischaemic heart disease: the case against. Digest Liver Dis 32:65–68, 2000

    Google Scholar 

  6. Realdi G, Dore P M, Fastame L: Extradigestive manifestations of H. pylori infection: Fact and fiction. Dig Dis Sci 44:229–236, 1999

    PubMed  Google Scholar 

  7. Patel P, Gasbarrini G, Pretolani S, Gasbarrini A, Franceshi F: Extradigestive diseases and H. pylori infection. Curr Opin Gastroenterol 13:52–55, 1997

    Google Scholar 

  8. Ekesbo R, Nilsson PM, Lindholm LH, Persson K, Wadstrom T: Combined seropositivity for H. pylori and C. pneumonia is associated with age, obesity and social factors. J Cardiovasc Risk 7:191–195, 2000

    Google Scholar 

  9. Mendall MA, Goggin PM, Molineaux N, et al.: Realation of H. pylori infection and coronary heart disease. Br Heart J 71:437–439, 1994

    PubMed  Google Scholar 

  10. Pasceri V, Cammarota G, Patti G, et al. : Association of virulent H. pylori strains with ischemic heart disease. Circulation 71:1675–1679, 1998

    Google Scholar 

  11. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R: H. pylori infection and early onset myocardial infection: Case–control and sibling pairs study. BMJ 319:1157–1162, 1999

    PubMed  Google Scholar 

  12. Strachan DP, Mendall MA, Carrington D, et al.: Relation of H. pylori infection to 13–year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation 98:1286–1290, 1998

    PubMed  Google Scholar 

  13. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY: H. pylori seropositivity and coronary heart disease incidence: Atherosclerosis risk in communities (ARIC) study investigators. Circulation 98:845–850, 1998

    PubMed  Google Scholar 

  14. Ridker PM, Danesh J, Youngman L, et al.: A prospective study of H. pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 135:184–188, 2001

    Google Scholar 

  15. Gallin JL, Kaye D, O’Leary WM: Serum lipid in infection. N Engl J Med 281:1081–1086, 1969

    PubMed  Google Scholar 

  16. Alvarez C, Ramos A: Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem Res 32:142–145, 1986

    Google Scholar 

  17. Kerttula Y, Weber T: Serum lipids in pneumonia of different aetiology. Ann Clin Res 20:184–188, 1988

    PubMed  Google Scholar 

  18. Grunfeld C, Gulli R, Moser AH, Gavin LA, Feingold KR: Effect of tumour necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res 30:579–585, 1989

    PubMed  Google Scholar 

  19. Kaukoranta-Tolvanan SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M: Growth of C. pneumonia in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 21:215–221, 1996

    Google Scholar 

  20. Lopes-Virella MF: Interactions between bacterial lipopolysaccharide and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J 14:118–124, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Baskent University Faculty of Medicine, Ankara, Turkey

    Mehmet Kanbay MD

  2. Department of Gastroenterology, Baskent University Faculty of Medicine, Ankara, Turkey

    Gürden Gür MD, Ugur Yilmaz MD & Sedat Boyacioĝlu MD

  3. Department of Infectious Disease, Baskent University Faculty of Medicine, Ankara, Turkey

    Hande Arslan MD

  4. 35 Sokak, 81/5, Bahcelievler 06490, Ankara, Turkey

    Mehmet Kanbay MD

Authors
  1. Mehmet Kanbay MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gürden Gür MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hande Arslan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ugur Yilmaz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sedat Boyacioĝlu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehmet Kanbay MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanbay, M., Gür, G., Arslan, H. et al. Does Eradication of Helicobacter pylori Infection Help Normalize Serum Lipid and CRP Levels?. Dig Dis Sci 50, 1228–1231 (2005). https://doi.org/10.1007/s10620-005-2764-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2764-9

Key Words

Search

Navigation